• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性化疗后胃肠道毒性的评估。

Evaluation of gastrointestinal toxicity following cytostatic chemotherapy.

作者信息

Smit J M, Mulder N H, Sleijfer D T, Bouman J G, Veeger W

出版信息

J Cancer Res Clin Oncol. 1986;111(1):59-61. doi: 10.1007/BF00402778.

DOI:10.1007/BF00402778
PMID:3081522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12252588/
Abstract

A number of clinical and chemical parameters related to the gastrointestinal tract in patients treated with intensive chemotherapy for disseminated malignant melanoma were evaluated in order to find quantitative indicators for gastrointestinal toxicity and to investigate the cause of diarrhea after chemotherapy. In 11 patients 17 courses of polychemotherapy with bleomycin, DTIC, vindesine, and actinomycin D were administered, while the patients received complete liquid enteral nutrition. As clinical parameters for toxicity the diarrhea grading system according to the WHO criteria and the daily fecal consistency were used. Furthermore, in the feces Na+, K+, and Cl- (mmol/24 h), Na+/K+ ratio, dry and wet weight (g/24 h), lactate and bile acids (mmol/24 h), fat (g/24 h), pH, and osmolarity were determined. Both clinical parameters were closely correlated. The most important effects of the chemotherapy on the chemical parameters were an increased fecal fluid, K+, and fat excretion. The fecal wet weight and K+ excretion showed a high correlation with the two clinical parameters for gastrointestinal toxicity. We conclude that mucosal injury resulting from chemotherapy probably leads to increased small intestinal fluid and electrolyte secretion inducing diarrhea and that fecal wet weight and K+ excretion are probably the best quantitative indicators for gastrointestincal toxicity.

摘要

为了寻找胃肠道毒性的定量指标并探究化疗后腹泻的原因,我们评估了接受强化化疗的播散性恶性黑色素瘤患者的一些与胃肠道相关的临床和化学参数。11例患者接受了17个疗程的包含博来霉素、达卡巴嗪、长春地辛和放线菌素D的联合化疗,同时患者接受全液量肠内营养。作为毒性的临床参数,使用了根据WHO标准的腹泻分级系统和每日粪便稠度。此外,测定了粪便中的Na+、K+和Cl-(mmol/24小时)、Na+/K+比值、干重和湿重(g/24小时)、乳酸和胆汁酸(mmol/24小时)、脂肪(g/24小时)、pH和渗透压。两个临床参数密切相关。化疗对化学参数的最重要影响是粪便液体、K+和脂肪排泄增加。粪便湿重和K+排泄与胃肠道毒性的两个临床参数高度相关。我们得出结论,化疗引起的黏膜损伤可能导致小肠液体和电解质分泌增加从而引发腹泻,并且粪便湿重和K+排泄可能是胃肠道毒性的最佳定量指标。

相似文献

1
Evaluation of gastrointestinal toxicity following cytostatic chemotherapy.细胞毒性化疗后胃肠道毒性的评估。
J Cancer Res Clin Oncol. 1986;111(1):59-61. doi: 10.1007/BF00402778.
2
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
3
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.首次就诊时磁共振灌注成像用于鉴别低级别与高级别胶质瘤
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
6
Nutritional support for liver disease.肝病的营养支持
Cochrane Database Syst Rev. 2012 May 16;2012(5):CD008344. doi: 10.1002/14651858.CD008344.pub2.
7
Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy.用于降低接受根治性盆腔放疗的成人胃肠道毒性的营养干预措施。
Cochrane Database Syst Rev. 2013 Nov 26;2013(11):CD009896. doi: 10.1002/14651858.CD009896.pub2.
8
Preoperative nutrition therapy in people undergoing gastrointestinal surgery.接受胃肠手术患者的术前营养治疗
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD008879. doi: 10.1002/14651858.CD008879.pub3.
9
Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.降低原发性盆腔癌盆腔放疗急慢性胃肠道不良反应的干预措施。
Cochrane Database Syst Rev. 2018 Jan 23;1(1):CD012529. doi: 10.1002/14651858.CD012529.pub2.
10
Effects of a veterinary gastrointestinal diet on fecal characteristics, metabolites, and microbiota concentrations of adult cats treated with metronidazole.兽医肠胃饮食对接受甲硝唑治疗的成年猫的粪便特征、代谢物和微生物群落浓度的影响。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae274.

本文引用的文献

1
Rapid method for the determination of fat in feces.粪便中脂肪测定的快速方法。
J Biol Chem. 1949 Jan;177(1):347-55.
2
QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS.粪便总胆汁酸的定量分离及气相色谱分析
J Lipid Res. 1965 Jul;6:397-410.
3
Diarrhoea caused by deficiency of sugar splitting enzymes. I.由糖分解酶缺乏引起的腹泻。一
Acta Paediatr (Stockh). 1961 Jan;50:55-71. doi: 10.1111/j.1651-2227.1961.tb08022.x.
4
Effect of leukemia and methotrexate on digestive enzymes in the jejunum of mice.白血病和甲氨蝶呤对小鼠空肠消化酶的影响。
Digestion. 1981;22(1):8-15. doi: 10.1159/000198589.
5
Enteral nutrition by nasogastric tube in adult patients treated with intensive chemotherapy for acute leukemia.急性白血病强化化疗成年患者经鼻胃管给予肠内营养
Am J Clin Nutr. 1982 Jun;35(6):1490-6. doi: 10.1093/ajcn/35.6.1490.
6
Crypts are the site of intestinal fluid and electrolyte secretion.肠腺是肠道分泌液体和电解质的部位。
Science. 1982 Dec 17;218(4578):1219-21. doi: 10.1126/science.6293054.
7
The contribution of the colon to electrolyte and water conservation in man.结肠在人体电解质和水分保持中的作用。
J Lab Clin Med. 1973 May;81(5):733-46.
8
Effects of cancer, radiotherapy and cytotoxic drugs on intestinal structure and function.癌症、放疗及细胞毒性药物对肠道结构与功能的影响。
Cancer Treat Rev. 1979 Sep;6(3):141-51. doi: 10.1016/s0305-7372(79)80066-3.
9
Reversible changes in duodenal mucosa associated with intensive chemotherapy followed by autologous marrow rescue.强化化疗后继自体骨髓挽救治疗相关的十二指肠黏膜可逆性改变。
Lancet. 1979 Sep 8;2(8141):532-3. doi: 10.1016/s0140-6736(79)91595-2.